Please ensure Javascript is enabled for purposes of website accessibility
top of page
N=1 Collaborative

Pharma can target ultra-rare conditions — the next step is financing them

  • Writer: N1C
    N1C
  • Sep 13, 2023
  • 1 min read

Updated: Sep 21, 2023

Jared Whitlock (Endpoints News)


July 27, 2023


As science has enabled care for previously untreatable, ultra-rare conditions, health systems and governments are struggling with ways of financing research and development of these therapies. What are the solutions when the science has progressed, but the economics haven't?




Pharma can target ultra-rare conditions - the next step is financing them. Endpoints Webinars. (n.d.). https://webinars.endpts.com/pharma-can-target-ultra-rare-conditions-the-next-step-is-financing-them/#:~:text=register%20to%20watch-,Pharma%20can%20target%20ultra%2Drare%20conditions%20—%20the%20next%20step%20is,and%20development%20of%20these%20therapies.

 
 
 

Comentários


Join Our Community List

Relationship Required
Area(s) of Interest Required

Thanks for submitting!

N=1 Collaborative

Contact Us

501c3 Nonprofit Organization

EIN: 88-2591503

©2024 by N=1 Collaborative

Crafted By: Finfrock Marketing

bottom of page